GRANT
NUMBER: NA66FD0103
NMFS NUMBER: 95-NWR-014
REPORT
TITLE:
Heterosigma carterae: Environmental Induction
of Toxin Production and Target Marine Species
AUTHOR:
Joseph F. Ammirati
PUBLISH
DATE:
September 3, 1999
AVAILABLE
FROM:
National Marine Fisheries Service, Northwest Region, 7600
Sand Point Way, N.E., BIN C15700, Seattle, Washington
98115-0070. TELEPHONE: (206) 526-6115
ABSTRACT

Heterosigma
carterae is a noxious alga that blooms globally in
temperate and subtropical regions. This study demonstrates
that Heterosigma produces a haemolytic toxin.
The toxin is sequestered in the cell and can be released
by subjecting the alga to freeze/thaw conditions. Heterosigma
cell extracts also display ichthyotoxic activity
and can impact normal physiogical response in Artemia.
Correlative field studies measured the effects
of a broad spectrum of environmental cues (e.g. nutrient
load, pH, dissolved oxygen, etc.) before and during a
Heterosigma bloom that occurred in 1997.
Data suggest, at least for this noxious event, that shallow
salinity and temperature stratification might be triggers
that induce rapid cell growth. The primary goal
of this project was to analyze the impact of specific
physiological cues on Heterosigma growth, and
to isolate and analyze the toxin(s) produced by Heterosigma
carterae. The secondary goal of this research was
to monitor the effect of Heterosigma toxin on
vertebrates and invertebrates. The data presented in the
text, demonstrates for the first time, that Heterosigma
produces a haemolytic toxin. The haemolysis of sheep red
blood cells with saponin as a reference control was used
as an assay. It was shown that this Heterosigma
toxin is sequestered and that the toxin does not loose
activity in frozen cells. Although a large effort was
expanded, no correlation between physiological cues and
cellular haemolytic toxin level was determined in these
studies. Collaborative studies with W. Gerwicks
laboratory identified a Heterosigma cellular
fraction caused severe diarrhea in brine shrimp. Heterosigma
cellular fractions were also analyzed through the National
Cancer Institute Therapeutic program.